Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK plc has announced the purchase of 494,426 of its own ordinary shares as part of ...

Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

GlaxoSmithKline Pharmaceuticals reports a 12% increase in net profit to Rs 279 crore for the June quarter despite a slight ...

In a report released today, Justin Smith from Bernstein maintained a Buy rating on GlaxoSmithKline, with a price target of £21.70. The company’s shares closed today at p1,373.00. Take advantage of ...

Net Sales at Rs 804.83 crore in June 2025 down 0.76% from Rs. 811.00 crore in June 2024. Quarterly Net Profit at Rs. 204.70 ...

GlaxoSmithKline (GSK-0.81%) has confirmed plans to separate its consumer and pharmaceutical business units. However, an activist investor appears to want the big drugmaker to take more drastic ...

July 14, 2010 -- In the face of mounting evidence that GlaxoSmithKline withheld important safety data on their controversial drug Avandia, some doctors are abandoning use of this diabetes treatment.

GlaxoSmithKline is accused in a lawsuit of using threats to block generic competition to its $2-billion-a-year antibiotic Augmentin after a U.S. judge eliminated the drug's patent protection.

A vaccine invented at drug giant GlaxoSmithKline and funded in part by the Bill & Melinda Gates Foundation cut the rate of malaria infection in small children roughly in half, providing real hope ...